×ðÁú¿­Ê±

EN
EN
  • ÓªÒµ×Éѯ

    Öйú£º

    Email: marketing@medicilon.com.cn

    ÓªÒµ×ÉѯרÏߣº400-780-8018

    £¨½öÏÞЧÀÍ×Éѯ £¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©

    ´¨É³×ܲ¿µç»°: +86 (21) 5859-1500

    ÍâÑó£º

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

ÔÚÏßÁôÑÔ¡Á
µã»÷Çл»
Customer Center
¿Í»§ÖÐÐÄ

ÂÞÊϿڷþPI3K¦ÁÒÖÖÆ¼ÁÒÁÄÇÀûÈûº£ÄÚ»ñÅúÉÏÊÐ | 1·ÖÖÓÒ©ÎÅËÙÀÀ

2025-03-16
|
»á¼ûÁ¿£º

0317.jpgÒ½ÏßÒ©ÎÅ

1. 3ÔÂ14ÈÕ £¬ÂÞÊÏ£¨Roche£©¸Õ¸ÕÐû²¼ÒÁÄÇÀûÈûƬÔÚÖйú»ñÅúÉÏÊÐ £¬ÁªºÏßß°ØÎ÷ÀûºÍ·úά˾Ⱥ £¬ÊÊÓÃÓÚÄÚÉøÍ¸ÖÎÁÆÄÍÒ©£¨°üÀ¨ÔÚ¸¨ÖúÄÚÉøÍ¸ÖÎÁÆÊ±´ú»òÖ®ºó·ºÆð¸´·¢£©¡¢PIK3CAÍ»±ä¡¢¼¤ËØÊÜÌ壨HR£©ÑôÐÔ¡¢ÈË±íÆ¤Éú³¤Òò×ÓÊÜÌå2£¨HER2£©ÒõÐԵľֲ¿ÍíÆÚ»ò×ªÒÆÐÔÈéÏÙ°©³ÉÈË»¼Õß¡£

2. ¿ËÈÕ £¬CDE¹ÙÍø¹«Ê¾ £¬Æ¤¶û·¨²®£¨Pierre Fabre£©É걨µÄ1ÀàÐÂÒ©STX-241Ƭ»ñµÃÁÙ´²ÊÔÑéĬʾÔÊÐí £¬Ä⿪·¢ÖÎÁƶÔÈý´úEGFR TKIÖÎÁÆÄÍÒ©µÄ¾Ö²¿ÍíÆÚ»ò×ªÒÆÐÔ·ÇСϸ°û·Î°© (NSCLC£©»¼Õß¡£ÕâÊÇÒ»¿î¸ßÑ¡ÔñÐԵĵÚËÄ´ú±íƤÉú³¤Òò×ÓÊÜÌ壨EGFR£©ÒÖÖÆ¼Á¡£

3. 3ÔÂ13ÈÕ £¬¸´ÐÇÒ½Ò©Ðû²¼¿Ø¹É×Ó¹«Ë¾Õã½­ÐǺÆÅ첩ҽҩÓÐÏÞ¹«Ë¾ÓÚ¿ËÈÕÊÕµ½¹ú¼ÒÒ©Æ·¼àÊÓÖÎÀí¾Ö¹ØÓÚÔÞ³ÉXH-S003½ºÄÒÓÃÓÚÖÎÁÆÕó·¢ÐÔ˯ÃßÐÔѪºìÂѰ×ÄòÖ¢£¨PNH£©¿ªÕ¹ÁÙ´²ÊÔÑéµÄÅú×¼¡£XH-S003Ϊ¸´ÐÇÒ½Ò©×ÔÖ÷Ñз¢µÄ²¹ÏµÒ»ÇÐС·Ö×ÓÒÖÖÆ¼Á £¬ÄâÓÃÓÚÖÎÁƲ¹ÌåÒì³£¼¤»îÏà¹ØµÄ¼²²¡¡£

4. 3ÔÂ13ÈÕ £¬CDE¹ÙÍøÐÂÎÅ £¬Òæ·½ÉúÎï¿Æ¼¼£¨ÉϺ££©¹É·ÝÓÐÏÞ¹«Ë¾ÁªºÏÉêÇëÒ©Æ·¡°D-2570Ƭ¡± £¬»ñµÃÁÙ´²ÊÔÑéĬʾÔÊÐí £¬Ë³Ó¦Ö¢£º±¾Æ·ÄâÓÃÓÚÀ£ÑñÐԽ᳦Ñ×µÄÖÎÁÆ¡£

ͶÈÚÒ©ÊÂ

1. 3ÔÂ12ÈÕ £¬ÂÞÊÏÐû²¼ £¬ÒÑÓë Zealand Pharma ¸æ¿¢¶À¼ÒÏàÖúÓëÔÊÐíЭÒé £¬ÅäºÏ¿ª·¢ºÍÉÌÒµ»¯³¤Ð§ÒȵíËØÀàËÆÎï petrelintide £¬×÷Ϊµ¥Ò©ÁÆ·¨ÒÔ¼°ÓëÂÞÊÏ GLP-1R/GIPR Ë«¼¤¶¯¼Á CT-388 ÐγÉÀο¿¼ÁÁ¿×éºÏ¡£ÉúÒâ×ܽð¶î´ï 53 ÒÚÃÀÔª¡£

2. 3ÔÂ12ÈÕ £¬ºÍ²¬Ò½Ò©Ðû²¼½¨Éè ?lanc¨¦ Therapeutics £¬½èÖúºÍ²¬Ò½Ò©×¨ÓеĻùÓÚÈ«ÈËÔ´ÖØÁ´¿¹Ì壨HCAb£©µÄË«ÌØÒìÐÔ¿¹ÌåÊÖÒÕ £¬¿ª·¢Õë¶Ô·ÊÅÖÖ¢µÄÁ¢ÒìÁÆ·¨ £¬ÒÔ½â¾öÄ¿½ñ·ÊÅÖÖ¢ÖÎÁÆÖаüÀ¨¼¡Èâ±£»¤ºÍºã¾ÃÁÆÐ§ÔÚÄÚµÈÒªº¦ÌôÕ½¡£

¿Æ¼¼Ò©ÑÐ

1. 3ÔÂ12ÈÕ £¬µÂ¹ú¶ùͯÇàÉÙÄ꿵½¡ÖÐÐÄMir-Farzin Mashreghi £¬°ØÁÖÏÄÀïÌØÒ½Ñ§ÔºTilmann Kallinich¡¢Carl Christoph GoetzkeÅäºÏͨѶÔÚ¡¶Nature¡·½ÒÏþÂÛÎÄ¡°TGF¦Â links EBV to multisystem inflammatory syndrome in children¡± £¬Õ¹ÏÖÁËDZÔÚ»úÖÆ £¬·¢Ã÷ϸ°ûÒò×Óת»¯Éú³¤Òò×Ó-¦Â£¨TGF¦Â£©¼°ÆäÓë°®ÆÃ˹̹-°Í¶û²¡¶¾£¨EBV£©µÄ¹ØÁªÆð×ÅÒªº¦×÷Óá£ÕâÏîÑо¿¹ØÓÚÃ÷È·ºÍÖÎÁÆ MIS-C ¾ßÓÐÖ÷ÒªÒâÒå¡£°ÐÏò TGF¦Â ¿ÉÄÜÊÇ»º½â MIS-C »¼ÕßÑ×Ö¢·´Ó¦ºÍÃâÒßʧµ÷µÄDZÔÚÖÎÁÆÕ½ÂÔ¡£

[1]Goetzke, C.C., Massoud, M., Frischbutter, S. et al. TGF¦Â links EBV to multisystem inflammatory syndrome in children. Nature (2025). https://doi.org/10.1038/s41586-025-08697-6


Ïà¹ØÐÂÎÅ
¡Á
ËÑË÷ÑéÖ¤
µã»÷Çл»
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿